Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Cellebrite DI (CLBT) EBT Margin: 2020-2025

Historic EBT Margin for Cellebrite DI (CLBT) over the last 5 years, with Sep 2025 value amounting to 19.27%.

  • Cellebrite DI's EBT Margin rose 21068.00% to 19.27% in Q3 2025 from the same period last year, while for Sep 2025 it was 18.49%, marking a year-over-year increase of 9852.00%. This contributed to the annual value of -68.79% for FY2024, which is 4555.00% down from last year.
  • According to the latest figures from Q3 2025, Cellebrite DI's EBT Margin is 19.27%, which was up 5.00% from 18.35% recorded in Q2 2025.
  • Over the past 5 years, Cellebrite DI's EBT Margin peaked at 87.29% during Q1 2022, and registered a low of -191.41% during Q3 2024.
  • Over the past 3 years, Cellebrite DI's median EBT Margin value was -13.27% (recorded in 2023), while the average stood at -28.94%.
  • As far as peak fluctuations go, Cellebrite DI's EBT Margin crashed by 19,955bps in 2024, and later surged by 21,068bps in 2025.
  • Quarterly analysis of 5 years shows Cellebrite DI's EBT Margin stood at 79.69% in 2021, then crashed by 6,739bps to 12.30% in 2022, then plummeted by 2,557bps to -13.27% in 2023, then soared by 3,152bps to 18.25% in 2024, then skyrocketed by 21,068bps to 19.27% in 2025.
  • Its last three reported values are 19.27% in Q3 2025, 18.35% for Q2 2025, and 17.97% during Q1 2025.